课题基金 / 基金详情

项目摘要

项目成果

ROBERT A SEDER的其他基金

相似基金

相关文献

中文摘要
翻译
今年的主要发现如下。
英文摘要
The major discovery this year are as follows. 1. Initiated a phase I clinical trial assessing whether irradiated PfSPZ given by the IV or IM route is safe, and confers durable immunity and protection using various doses and intervals for immunization. 2. Characterized the sporozoite specific T cell and NK responses longitudinally following vaccination and infection to provide insights into the correlates of protection. Used Fluidigm to characterize the heterogeneity of the sporozoite specific CD4+ T cell response in vaccinated/protected versus vaccinated/unprotected or control infected subjects. 3. Isolated monoclonal antibodies against malaria specific proteins ( eg CSP) in vaccinated and protected subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VACCINE DEVELOPMENT FOR TUBERCULOSIS
  • 批准号:
    7958684
  • 项目类别:
  • 资助金额:
    $5.57万
  • 财政年份:
    2009
  • 负责人:
    ROBERT A SEDER
  • 依托单位:
DNA VACCINATION FOR PREVENTION OF VIRAL, PARASITIC AND MYCOBACTERIAL INFECTION
Development Of A Vaccine For Leishmania Major Infection
Development Of A Vaccine For Leishmania Major Infection
海外基金